Answers are grounded in this paper and cite their sources.
Engineered dressing shows ≥90% bacterial eradication in infected wounds, indicating improved healing outcomes.
Infected wound healing environments present dual challenges of microbial colonization and sustained oxidative stress, critically impairing patient outcomes. Developing advanced dressings capable of concurrent broad-spectrum antimicrobial action and redox homeostasis restoration remains an urgent clinical priority. Here, we engineered a multifunctional porcine small intestinal submucosa extracellular matrix dressing (i.e., SISTP) integrated with AI-screened antimicrobial peptides (AMPs) via tea polyphenol-mediated coordination. The CRRI6 hexapeptide (Arg-Trp-Trp-Arg-Trp-Phe) demonstrated prolonged release kinetics (>6 hours) from the SISTP scaffold, achieving ≥90% eradication of Escherichia coli and Staphylococcus aureus. Radical scavenging assays confirmed SISTP’s capacity to neutralize reactive oxygen species (ROS), while in vivo studies revealed accelerated wound closure in infected rat models through synergistic microbial clearance and oxidative stress mitigation. This study pioneers a bioinspired strategy leveraging AI-optimized AMPs and polyphenol nanoengineering to address the multifactorial pathophysiology of chronic wounds.
No takes yet. Share an insight, caveat, or question.
Yue et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: